Your session is about to expire
← Back to Search
Behavioural Intervention
A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma
N/A
Waitlist Available
Led By Heather Livengood, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Summary
This trial tests a new electric current treatment for people with glaucoma to improve their vision and quality of life by stimulating underperforming parts of their eyes and brain.
Eligible Conditions
- Glaucoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Humphrey Visual Field Analyzer Score
Change in Macular Ganglion Cell-Inner Plexiform Layer Thickness
Change in Minnesota Low Vision Reading Test (MNRead): Reading Acuity Score
+17 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: rtACS Stimulation GroupExperimental Treatment1 Intervention
Group II: Sham Intervention GroupPlacebo Group1 Intervention
Sham stimulation looks like rtACS, but is not active rtACS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
rtACS Stimulation
2017
N/A
~20
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,059 Total Patients Enrolled
9 Trials studying Glaucoma
5,509 Patients Enrolled for Glaucoma
Heather Livengood, PhDPrincipal InvestigatorNYU Langone Health
Joel Schuman, MD, FACSPrincipal InvestigatorNYU Langone Health